Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Adaptive Biotechnologies Corp Director's Dealing 2019

Jul 3, 2019

31660_dirs_2019-07-03_ab5d9bfc-be2d-42c2-8546-b03cbf2ad8e1.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Adaptive Biotechnologies Corp (ADPT)
CIK: 0001478320
Period of Report: 2019-07-01

Reporting Person: HILL NANCY LOUISE (Sr Vice President, Operations)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2019-07-01 Common Stock P 10000 $20 Acquired 10000 Direct
2019-07-01 Common Stock P 500 $20 Acquired 500 Indirect
2019-07-01 Common Stock P 400 $20 Acquired 400 Indirect
2019-07-01 Common Stock P 300 $20 Acquired 300 Indirect

Footnotes

F1: The reporting person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein.